antibody targets protein found surface influenza viruses called hemagglutinin known antibody found bind subtypes influenza virus hemagglutinin hoped useful universal influenza virus antibody binds f domain ha trimer prevents virus attaching host cell antibody refined order remove excess unstable mutations could negatively affect neutralising ability new version antibody termed researchers britain switzerland previously found antibodies work group influenza viruses group viruses team developed method using singlecell screening test large numbers human plasma cells increase odds finding antibody even extremely identified injected mice ferrets found protected animals infection either group group influenza scientists screened peripheralblood plasma cells eight recently infected vaccinated donors antibodies recognize three diverse influenza strains swineorigin highly pathogenic avian influenzas one donor isolated four plasma cells produced identical antibody called antibody binds ha subtypes neutralizes infection protects mice ferrets lethal infection broadly reactive antibodies previously discovered recognized either one group ha subtypes highlighting remarkable ability target gamut influenza researchers determined crystal structure antibody bound ha proteins sitting atop ha spike globular head domain binds cellular receptors viral entry contains major antigenic sites targeted immune system selective pressure sequence head domain drifts enough require updated seasonal vaccine years stalk domain connects head viral membrane responsible fusing viral host membranes pathogen invade human cells immune system usually strong response partially hidden stalk domain portions stalk remain highly conserved across influenza subtypes antibody makes extensive contacts conserved parts stalk thereby blocking ha harpooning sticky fusion peptide host membrane viral entry provides scientists broadly neutralizing antibody recognizes ha subtypes including emerging ones replication influenza virus somewhat errorprone virus evolves quasispecies widespread use antiviral drugs lead resistant strains case oseltamivir ion channel blocker amantadine therefore considering longterm prophylactic therapeutic agent seasonal influenza would first determine whether influenza virus could quickly mutate epitope targeted escape recognition exposure important clinical implication work identification universal neutralizing epitope ha stalk atomic level important intellectual landmark development universal influenza vaccine absence immunodominant head domain isolated portions ha stalk include epitope already shown stimulate broad universal protective effects strains vaccinated animals using protein engineering adjuvants focus immune system epitope may critical next step along path universal